Protalix BioTherapeutics (PLX) Asset Utilization Ratio (2010 - 2026)
Protalix BioTherapeutics' (PLX) Asset Utilization Ratio stood at 0.76 in Q2 2026, down 6.8% from 0.81 a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
For FY2025, Protalix BioTherapeutics' Asset Utilization Ratio came in at 0.68, up 0.1% from FY2024.
- Across earlier years, Asset Utilization Ratio came in at 0.68 in FY2024 (-27.6%), 0.93 in FY2023 (+26.9%), 0.74 in FY2022 (+35.9%) and 0.54 in FY2021 (-51.2%).
- Quarterly Asset Utilization Ratio has ranged from 0.42 in Q2 2024 to 0.87 in Q2 2023 over the past five years.
- On a year-over-year basis, Asset Utilization Ratio rose in five of the last eight quarters, with growth averaging 13.0%.
- Peak year-over-year performance for Asset Utilization Ratio in the last five years was growth of 93.8% in Q2 2025, against a decline of 51.8% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.83 (Q1 2026), 0.64 (Q4 2025) and 0.77 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 0.74 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.74 |
| Jun 30, 2026 | 0.76 |
| Mar 31, 2026 | 0.83 |
| Dec 31, 2025 | 0.64 |
| Sep 30, 2025 | 0.77 |
| Jun 30, 2025 | 0.81 |
| Mar 31, 2025 | 0.81 |
| Dec 31, 2024 | 0.79 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.42 |
| Mar 31, 2024 | 0.68 |
| Dec 31, 2023 | 0.76 |
| Sep 30, 2023 | 0.72 |
| Jun 30, 2023 | 0.87 |
| Mar 31, 2023 | 0.67 |
| Dec 31, 2022 | 0.85 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 0.70 |
| Mar 31, 2022 | 0.61 |
| Dec 31, 2021 | 0.49 |
API Access
Protalix BioTherapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();